Spots Global Cancer Trial Database for stage iii pancreatic cancer
Every month we try and update this database with for stage iii pancreatic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | NCT00002689 | Pancreatic Canc... | dexamethasone fluorouracil brachytherapy phosphorus P32 radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer | NCT00274885 | Cancer | oxaliplatin management of t... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery | NCT00004003 | Pancreatic Canc... | cisplatin fluorouracil gemcitabine hyd... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | NCT00003216 | Pancreatic Canc... | fluorouracil gemcitabine hyd... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer | NCT00547612 | Pancreatic Canc... | high performanc... pharmacological... [18F]-labeled s... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery | NCT01473940 | Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... | ipilimumab gemcitabine hyd... laboratory biom... | 18 Years - | Northwestern University | |
| BMS-247550 in Treating Patients With Advanced Pancreatic Cancer | NCT00016965 | Pancreatic Canc... | ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine | NCT00053222 | Pancreatic Canc... | arsenic trioxid... | 18 Years - | University of Chicago | |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers | NCT01846520 | Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung... | educational int... telephone-based... quality-of-life... questionnaire a... | 18 Years - | City of Hope Medical Center | |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer | NCT02048943 | Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... Unspecified Adu... | dovitinib lacta... gemcitabine hyd... paclitaxel albu... pharmacological... laboratory biom... | 18 Years - | Roswell Park Cancer Institute | |
| MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery | NCT01098344 | Pancreatic Canc... | Notch signaling... gemcitabine hyd... imaging biomark... laboratory biom... pharmacological... | 18 Years - | Cancer Research UK | |
| Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | NCT00323583 | Adenocarincoma ... Stage III Pancr... Stage IVA Pancr... Stage IVB Pancr... | paclitaxel oxaliplatin leucovorin 5-fluorouracil glutathione calcium and mag... Chemotherapy Chemoprotection Complementary a... | 18 Years - 65 Years | Seattle Cancer Treatment and Wellness Center | |
| Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients | NCT00383760 | Adenocarcinoma ... Pancreatic Canc... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre... | eribulin mesyla... | 18 Years - | National Cancer Institute (NCI) | |
| Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer | NCT02227940 | Advanced Malign... ALK Positive Metastatic Panc... Stage III Pancr... Stage IV Pancre... | Ceritinib Cisplatin Gemcitabine Hyd... Laboratory Biom... Paclitaxel Albu... Pharmacological... | 18 Years - | Roswell Park Cancer Institute | |
| Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study | NCT02345460 | Pancreatic Aden... Poorly Differen... Resectable Panc... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Undifferentiate... | Irinotecan Hydr... Oxaliplatin Leucovorin Calc... Fluorouracil Laboratory Biom... | 18 Years - 75 Years | Case Comprehensive Cancer Center | |
| Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors | NCT00352131 | Non-colorectal ... Pancreatic Canc... | HuC242-DM4 | 18 Years - | ImmunoGen, Inc. | |
| Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors | NCT02897375 | Solid Neoplasm Stage III Pancr... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Non-Sm... Stage IVA Pancr... Stage IVB Pancr... Sarcoma Colorectal Canc... Head and Neck C... Cancer of Unkno... Bladder Cancer Ovarian Cancer | Carboplatin Cisplatin Palbociclib | 18 Years - | Emory University | |
| Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer | NCT00059982 | Pancreatic Canc... | perifosine | 18 Years - | National Cancer Institute (NCI) | |
| Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | NCT00058201 | Pancreatic Canc... | fluorouracil gemcitabine hyd... leucovorin calc... clinical observ... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer | NCT01959672 | Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | 4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con... | 19 Years - | University of Nebraska | |
| Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy | NCT02414100 | Pancreatic Duct... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... | Laboratory Biom... Cytology Specim... | 18 Years - | Thomas Jefferson University | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer | NCT00026403 | Pancreatic Canc... | cisplatin gemcitabine hyd... radiation thera... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer | NCT00003411 | Extrahepatic Bi... Gallbladder Can... Pancreatic Canc... | motexafin gadol... radiation thera... | 18 Years - 120 Years | University of Pittsburgh | |
| Chemoradiation in Locally Advanced Pancreatic Cancer | NCT00262951 | Pancreatic Canc... | recombinant int... cisplatin fluorouracil radiation thera... Resection of tu... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer | NCT00004861 | Pancreatic Canc... | gemcitabine hyd... tacedinaline | 18 Years - | Pfizer | |
| Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | NCT01017822 | Pancreatic Canc... | conatumumab capecitabine gemcitabine hyd... 3-dimensional c... | 18 Years - | Radiation Therapy Oncology Group | |
| Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers | NCT00684801 | Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc... | questionnaire a... quality-of-life... | 18 Years - | Case Comprehensive Cancer Center | |
| Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | NCT00003029 | Pancreatic Canc... | cisplatin fluorouracil | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers | NCT01497392 | Adenocarcinoma ... Stage III Pancr... Stage IV Pancre... Unspecified Adu... | dovitinib lacta... gemcitabine hyd... capecitabine laboratory biom... enzyme-linked i... pharmacological... | 18 Years - | Roswell Park Cancer Institute | |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer | NCT00026403 | Pancreatic Canc... | cisplatin gemcitabine hyd... radiation thera... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer | NCT03095781 | Colorectal Aden... Metastatic Panc... Recurrent Color... Recurrent Pancr... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... Unresectable Pa... | XL888 Pembrolizumab | 18 Years - | Emory University | |
| Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas | NCT00003780 | Pancreatic Canc... | tumor infiltrat... gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | NCT00025532 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | iodine I 131 mo... | 19 Years - | University of California, San Francisco | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | NCT00238199 | Pancreatic Canc... | calcitriol docetaxel | 18 Years - | OHSU Knight Cancer Institute | |
| Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | NCT00005869 | Pancreatic Canc... | gemcitabine hyd... rubitecan | 18 Years - | National Cancer Institute (NCI) | |
| Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery | NCT01234935 | Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem... | 18 Years - | Translational Oncology Research International | |
| Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies | NCT01643499 | Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex... | oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom... | 18 Years - | University of Chicago | |
| Individualized Drug Treatment for Treating Patients With Pancreatic Cancer | NCT00276744 | Pancreatic Canc... | cetuximab capecitabine docetaxel Erlotinib Gemcitabine Irinotecan mitomycin C rapamycin conventional su... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors | NCT02897375 | Solid Neoplasm Stage III Pancr... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Non-Sm... Stage IVA Pancr... Stage IVB Pancr... Sarcoma Colorectal Canc... Head and Neck C... Cancer of Unkno... Bladder Cancer Ovarian Cancer | Carboplatin Cisplatin Palbociclib | 18 Years - | Emory University | |
| Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | NCT00266097 | Extrahepatic Bi... Gallbladder Can... Pancreatic Canc... | erlotinib hydro... gemcitabine hyd... oxaliplatin radiation thera... gemcitabine hyd... Oxaliplatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers | NCT01497392 | Adenocarcinoma ... Stage III Pancr... Stage IV Pancre... Unspecified Adu... | dovitinib lacta... gemcitabine hyd... capecitabine laboratory biom... enzyme-linked i... pharmacological... | 18 Years - | Roswell Park Cancer Institute | |
| Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer | NCT00005648 | Pancreatic Neop... | Gemcitabine wit... Gemcitabine wit... | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer | NCT00063947 | Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... | erlotinib hydro... gemcitabine hyd... radiation thera... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer | NCT00478010 | Colorectal Canc... Pancreatic Canc... Psychosocial Ef... | counseling inte... study of socioe... psychosocial as... quality-of-life... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | NCT00003125 | Breast Cancer Esophageal Canc... Gastric Cancer Lung Cancer Pancreatic Canc... Unspecified Adu... | ALVAC-CEA vacci... aldesleukin sargramostim vaccinia-CEA va... | 18 Years - | Georgetown University | |
| Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | NCT00068575 | Pancreatic Canc... | Recombinant Int... Cisplatin Fluorouracil Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer | NCT00026104 | Adenocarcinoma ... Stage II Pancre... Stage III Pancr... | gemcitabine hyd... paclitaxel tipifarnib radiation thera... | - | National Cancer Institute (NCI) | |
| Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma | NCT00075452 | Pancreatic Canc... | gemcitabine hyd... oxaliplatin | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | NCT00544193 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera... | 18 Years - 70 Years | City of Hope Medical Center | |
| Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer | NCT01327794 | Pancreatic Canc... | polymorphism an... immunologic tec... laboratory biom... medical chart r... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer | NCT00966706 | Pancreatic Canc... | capecitabine cisplatin docetaxel epirubicin hydr... gemcitabine hyd... | 18 Years - 75 Years | IRCCS San Raffaele | |
| Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders | NCT00830557 | Islet Cell Tumo... Pancreatic Canc... Pancreatic Dise... | medical chart r... survey administ... biospecimen col... | 18 Years - 120 Years | Mayo Clinic | |
| Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer | NCT02349867 | Pancreatic Aden... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Recurrent Pancr... | Gemcitabine Sorafenib Vorinostat 3-Dimensional C... Intensity-Modul... RosetteSep DEPfff | 18 Years - | Virginia Commonwealth University | |
| Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors | NCT03682289 | Clear Cell Rena... Locally Advance... Locally Advance... Metastatic Mali... Metastatic Rena... Metastatic Urot... Metastatic Panc... Stage III Pancr... Stage III Renal... Stage IV Pancre... Stage IV Renal ... Endometrial Can... Metastatic Cast... | Ceralasertib Olaparib Durvalumab | 18 Years - | University of California, San Francisco | |
| Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery | NCT00003798 | Pancreatic Canc... | motexafin gadol... radiation thera... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Pancreatic Cancer Collaborative Registry | NCT00661882 | Pancreatic Canc... | medical chart r... questionnaire a... study of socioe... biopsy | 19 Years - 100 Years | University of Nebraska | |
| Individualized Drug Treatment for Treating Patients With Pancreatic Cancer | NCT00276744 | Pancreatic Canc... | cetuximab capecitabine docetaxel Erlotinib Gemcitabine Irinotecan mitomycin C rapamycin conventional su... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | NCT00010270 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | LMB-9 immunotox... | 18 Years - | National Cancer Institute (NCI) | |
| Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas | NCT00079365 | Pancreatic Canc... | fluorouracil gemcitabine hyd... brachytherapy phosphorus P32 radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer | NCT01927393 | Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Stage III Pancr... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIC Ovar... Stage IIIC Ovar... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... | palliative care educational int... quality-of-life... questionnaire a... telephone-based... | 21 Years - | City of Hope Medical Center | |
| Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | NCT00266097 | Extrahepatic Bi... Gallbladder Can... Pancreatic Canc... | erlotinib hydro... gemcitabine hyd... oxaliplatin radiation thera... gemcitabine hyd... Oxaliplatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors | NCT00369109 | Breast Cancer Colorectal Canc... Pancreatic Canc... | biologic sample... immunohistochem... laboratory biom... biopsy | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer | NCT00019084 | Breast Cancer Cervical Cancer Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc... | aldesleukin mutant p53 pept... ras peptide can... sargramostim therapeutic aut... therapeutic tum... | 18 Years - | National Cancer Institute (NCI) | |
| Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | NCT00238199 | Pancreatic Canc... | calcitriol docetaxel | 18 Years - | OHSU Knight Cancer Institute | |
| Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer | NCT02333188 | Adenocarcinoma ... Adult Cholangio... Gallbladder Car... Gastric Adenoca... Malignant Gastr... Metastatic Panc... Pancreatic Aden... Stage III Ampul... Stage III Pancr... Stage IIIA Gall... Stage IIIA Gast... Stage IIIB Gall... Stage IIIB Gast... Stage IV Ampull... Stage IV Gallbl... Stage IV Gastri... Stage IV Pancre... | Paclitaxel Albu... Leucovorin Calc... Irinotecan Hydr... Fluorouracil Laboratory Biom... | 18 Years - | University of Chicago | |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer | NCT02048943 | Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... Unspecified Adu... | dovitinib lacta... gemcitabine hyd... paclitaxel albu... pharmacological... laboratory biom... | 18 Years - | Roswell Park Cancer Institute | |
| Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer | NCT00047307 | Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre... | alvocidib gemcitabine hyd... 3-dimensional c... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas | NCT00003810 | Pancreatic Canc... | docetaxel gemcitabine hyd... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer | NCT00281996 | Pancreatic Canc... | Gemcitabine Imatinib mesyla... | 18 Years - | Northwestern University | |
| Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | NCT00095966 | Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre... | sorafenib tosyl... gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | NCT00088894 | Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre... | gemcitabine hyd... bevacizumab placebo laboratory biom... pharmacogenomic... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery | NCT02896907 | Pancreatic Aden... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa... | Oxaliplatin Irinotecan Hydr... Leucovorin Calc... Fluorouracil Ascorbic Acid | 18 Years - 75 Years | Thomas Jefferson University | |
| Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer | NCT03825289 | Metastatic Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa... | Hydroxychloroqu... Trametinib | 18 Years - | University of Utah | |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | NCT00436410 | Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma | colloidal gold-... electron micros... pharmacological... conventional su... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | NCT00489515 | Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | 18 Years - 120 Years | Wake Forest University Health Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
